Abstract 656: Antitumor activity of combined therapy with the class I BRAF inhibitor PLX4032 and immunotherapy
Year: 2011
Type: conference-abstract
Source: Cancer Research
Institution: University of California, Los Angeles
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2008090849